Infliximab: An alternative treatment for refractory immune thrombocytopenic purpura related to Crohn's disease? [3]

Inflammatory Bowel Diseases

Volumn 13, Issue 11, 2007, Pages 1452-1453

  Lazaraki, Georgia ^a   Metallidis, Simeon ^b   Giannoulis, Kleanthis ^a   Tarpagos, Anestis ^c   Germanidis, Georgios ^a  

^a PAPAGEORGIOU GENERAL HOSPITAL   (Greece)

^b AHEPA UNIVERSITY HOSPITAL   (Greece)

^c THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INFLIXIMAB; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; B LYMPHOCYTE; CROHN DISEASE; CYTOLYSIS; DISEASE COURSE; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; HELPER CELL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNE RESPONSE; LETTER; PRIORITY JOURNAL; SINGLE DRUG DOSE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CROHN DISEASE; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; SALVAGE THERAPY;

EID: 36749044311     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20209     Document Type: Letter

References (8)

1. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521-533.
2. Kuloglou Z, Kansu A, Demirceken F, et al. The association of chronic recurrent idiopathic thrombocytopenic purpura and Crohn's disease. Inflamm Bowel Dis. 2005;11:950-951.
3. Schleinitz N, Faure V, Bernit E, et al. Autoimmune thrombotic thrombocytopenic purpura: a severe complication of inflammatory bowel disease. J Clin Gastroenterol. 2003;36:83-84.
4. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995-1008.
5. Lugering A, Schmidt M, Lugering N, et al. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology. 2001;121:1145-1157.
6. Van Deventer SJH. Transmembrane TNF-alpha, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's disease. Gastroenterology. 2001;121:1242-1246.
7. Selby L, Hess D, Shashidar D, De Villiers WJS. Crohn's disease, infliximab and idiopathic thrombocytopenic purpura. Inflamm Bowel Dis. 2004;10:698-700.
8. Germanidis G, Lazaraki G, Gintikas G, et al. Refractory Crohn-associated acute immune thrombocytopenic purpura treated with infliximab: a proposed pathogenetic mechanism. Eur J Intern Med. 2007; doi: 10.1016/j.ejim.2006.11.012